Welcome to our dedicated page for Dorman Products SEC filings (Ticker: DORM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Dorman Products, Inc. filings document the company’s motor vehicle aftermarket operations, segment reporting and public-company governance. Its 8-K reports record operating results, financial condition updates, guidance-related disclosures, cash flow discussion, share repurchases and segment performance across Light Duty, Heavy Duty and Specialty Vehicle.
Proxy materials cover annual meeting matters, director elections, executive compensation, auditor ratification and equity incentive plan proposals. Other current reports document executive appointments, officer transition arrangements and related compensatory terms, tying governance changes to Dorman’s management structure and disclosure obligations.
Dorman Products (DORM) filed a Form 144 proposing the sale of 1,213 shares of common stock through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $181,950 and an approximate sale date of 08/12/2025. The filing shows those 1,213 shares were acquired on 02/28/2025 through restricted stock vesting and paid as compensation on the same date.
The filing lists total shares outstanding of 30,534,243 and discloses a prior sale on 07/28/2025 of 820 shares that generated $100,211.63. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Dorman Products, Inc. (DORM) filed a Form 144 reporting a proposed sale of 2,231 common shares with an aggregate market value of $317,597.63. The filing lists 30,534,243 shares outstanding and an approximate sale date of 08/11/2025 on NASDAQ.
The securities were acquired by the filer through stock option exercises (618 shares on 04/26/2018; 859 shares on 03/03/2023) and restricted stock vesting (754 shares on 03/01/2024), with payment described as cash for the exercises and compensation for the vesting. The filing notes Nothing to Report for sales during the past three months and includes the standard attestation that the filer does not know of undisclosed material adverse information. Submission is marked LIVE.
Form 4 – Dorman Products, Inc. (DORM)
SVP & CIO Donna M. Long reported two open-market sales on 28 Jul 2025:
- 2 common shares at a weighted average price of $121.60
- 818 common shares at a weighted average price of $122.2108
Aggregate shares sold: 820, for gross proceeds of roughly $100,000. Post-sale direct ownership declines to 19,073.8738 shares, a reduction of about 4 % of her prior position. No derivative securities were exercised or acquired, and no 10b5-1 trading plan is referenced.
The filing is routine and does not indicate any corporate events or financial performance issues. Given the modest size relative to both Long’s remaining stake and Dorman’s ~30 million-share float, the transaction is unlikely to exert meaningful pressure on the stock, but investors may track insider activity as a sentiment gauge.
Dorman Products, Inc. (DORM) filed a Form 144 disclosing a planned discretionary sale by an affiliate/insider of 820 common shares—valued at approximately $100,040—through Fidelity Brokerage Services on or about 28 July 2025. The stake equals roughly 0.003 % of the company’s 30,511,174 shares outstanding and therefore is immaterial to float and daily trading volume.
The shares originated from restricted-stock vesting on 6 Mar 2022 and constitute non-cash compensation. The filer reports no other sales in the prior three months and certifies lack of undisclosed adverse information. While insider transactions can signal sentiment, the modest dollar amount and percentage suggest limited market impact.